Presentation is loading. Please wait.

Presentation is loading. Please wait.

TEMPLATE DESIGN © 2008 www.PosterPresentations.com Management Challenge of Thrombophilia in Pregnancy-Case Report Dr. Gabriel Onyeka Ekekwe, Dr. Tempest.

Similar presentations


Presentation on theme: "TEMPLATE DESIGN © 2008 www.PosterPresentations.com Management Challenge of Thrombophilia in Pregnancy-Case Report Dr. Gabriel Onyeka Ekekwe, Dr. Tempest."— Presentation transcript:

1 TEMPLATE DESIGN © 2008 www.PosterPresentations.com Management Challenge of Thrombophilia in Pregnancy-Case Report Dr. Gabriel Onyeka Ekekwe, Dr. Tempest Nicola, Mrs. Sandhya Rao St Helens & Knowsley Teaching Hospitals NHS Whiston Hospital, Warrington Road, Prescot, L35 5DR I ntroduction  The risk of thromboembolism is increased significantly in pregnancy.  The risk is further increased in patients with thrombophilia.  Therefore, the use of anticoagulant in pregnancy is mandatory in these patients  Low molecular weight heparin like clexane is the first line anticoagulant in pregnancy (1)  Bleeding complications are rare with the use of clexane in pregnancy (1)  However, when bleeding occurs it pose a management dilemma as in the case report presented.  Retrievable vena cava filters has been found to be a safe alternative as was used in our patient(2,3) Case Report  The patient is a 33 year old G3P2 (Two previous caeserean sections, last section was 8 years ago)  She is a known thrombophilia (Heterozygous prothrombin gene mutation) with strong positive family history  Her father and brother died of heart attack and pulmonary embolism at the age of 37 and 30 years respectively  She smokes about 10 sticks of cigarrettes a day  Her BMI was 38kg/m2  She has had three previous episodes of major thromboembolic events. The last episode was a saddle pulmonary embolism 4 years ago (see CTPA showing saddle embolus)  Her long term Warfarin treatment was change to clexane (dose of clexane at1mg/kg x patient’s weight of 114kg=114mg in two divided doses) at 8 weeks gestation when USS confirmed intrauterine viable pregnancy  She opted to continue with the pregnancy as the risk of fetal anomaly was perceived to be small  She presented with massive broad ligament hematoma at 22 week gestation, hence the management challenge (see USS showing haematoma)  Clexane was discontinued following consultation with the Haematologist  A retrievable vena cava filter was inserted  She had a favourable pregnancy out come. She had an elective caesarean section and bilateral tubal ligation (previous two c-sections) at 36 weeks gestation. Baby birth weight was 3.195kg Discussions  The use of anticoagulant in pregnancy is mandatory in patients with thrombophilia  Low molecular weight heparin like clexane is the first line anticoagulant in pregnancy (1)  Clexane pose minimal risk of bleeding complication  However, it did occur in our patient and was discontinued  A retrievable VCF was then inserted  Anatomic consideration makes infrarenal VCF technically difficult in pregnancy. However, infrarenal VCF was successfully inserted in our patient  Suprarenal VCF offers an easier alternative, however, its potential thrombogenicity with possible renal compromise demand caution with this approach(4) Conclusions  Retrievable VCF is safe alternative to anticoagulant treatment for pregnant women with increased risk of thromboembolism that are intolerant or for some reasons unsuitable for anticoagulant treatment  It should also be considered in patient with thromboembolism despite adequate anticoagulant treatment References  1. Royal College of Obstetricians and Gynaecologists. ‘The Acute Management of Thrombosis and Embolism during Pregnancy and Puerperium’, Green top Guideline No. 37b, London: RCOG Press, 2007  2. Cipolla, J. et al (2008) ‘Complications of vena cava filters: A comprehensive clinical review’, OPUS 12 Scientist, vol. 2 (2); pp. 11- 24.  3. Gupta, S., Ettles, D.F., Robinson, G.J., and Lindow, S.W. (2008) ‘Inferior vena cava filter use in pregnancy: preliminary experience’, BJOG, vol. 115 (6); pp. 785-788.  4. Greenfield, L.J., Cho, K.J., Proctor, M.C., Sobel, M., Shah, S., and Wingo, J. (1992) ‘Late results of suprarenal Greenfield vena cava filter placement’, Arch Surg. 127; pp. 969-973.


Download ppt "TEMPLATE DESIGN © 2008 www.PosterPresentations.com Management Challenge of Thrombophilia in Pregnancy-Case Report Dr. Gabriel Onyeka Ekekwe, Dr. Tempest."

Similar presentations


Ads by Google